| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Pre-Eclampsia | 86 | 2020 | 255 | 6.540 |
Why?
|
| Pregnancy | 201 | 2020 | 3035 | 4.180 |
Why?
|
| Pregnancy Complications | 47 | 2014 | 345 | 3.230 |
Why?
|
| Pregnancy Complications, Cardiovascular | 37 | 2009 | 109 | 2.310 |
Why?
|
| Eclampsia | 17 | 2014 | 24 | 1.860 |
Why?
|
| Hypertension | 45 | 2020 | 745 | 1.770 |
Why?
|
| Scientific Misconduct | 3 | 2017 | 10 | 1.760 |
Why?
|
| Pregnancy Outcome | 18 | 2011 | 255 | 1.320 |
Why?
|
| Kidney | 61 | 2006 | 1147 | 1.300 |
Why?
|
| Arginine Vasopressin | 30 | 1998 | 44 | 1.130 |
Why?
|
| Water-Electrolyte Balance | 28 | 1995 | 67 | 1.120 |
Why?
|
| Kidney Diseases | 22 | 2007 | 320 | 1.110 |
Why?
|
| Female | 209 | 2020 | 46328 | 0.950 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-1 | 5 | 2015 | 94 | 0.840 |
Why?
|
| Proteinuria | 14 | 2020 | 67 | 0.830 |
Why?
|
| Pregnancy, Animal | 18 | 1996 | 58 | 0.820 |
Why?
|
| Fetal Development | 3 | 2017 | 31 | 0.810 |
Why?
|
| Urine | 6 | 2015 | 92 | 0.790 |
Why?
|
| Pregnancy Complications, Infectious | 6 | 2014 | 118 | 0.780 |
Why?
|
| Birth Weight | 5 | 2017 | 148 | 0.750 |
Why?
|
| Hypertension, Pregnancy-Induced | 6 | 2020 | 77 | 0.730 |
Why?
|
| Fetus | 5 | 2014 | 232 | 0.690 |
Why?
|
| Humans | 192 | 2020 | 89500 | 0.680 |
Why?
|
| Puerperal Disorders | 4 | 2008 | 32 | 0.650 |
Why?
|
| Renal Insufficiency, Chronic | 3 | 2020 | 220 | 0.620 |
Why?
|
| Antihypertensive Agents | 11 | 2011 | 251 | 0.620 |
Why?
|
| Blood Volume | 9 | 2009 | 49 | 0.610 |
Why?
|
| Aldosterone | 16 | 2009 | 56 | 0.580 |
Why?
|
| Diabetes Insipidus | 8 | 2005 | 17 | 0.550 |
Why?
|
| Severity of Illness Index | 11 | 2014 | 1849 | 0.550 |
Why?
|
| Glomerular Filtration Rate | 34 | 2020 | 276 | 0.540 |
Why?
|
| Sodium | 32 | 1988 | 331 | 0.530 |
Why?
|
| Pregnancy Proteins | 5 | 2015 | 37 | 0.520 |
Why?
|
| Vasopressins | 11 | 2005 | 50 | 0.520 |
Why?
|
| Pyuria | 1 | 2015 | 2 | 0.510 |
Why?
|
| Abnormalities, Drug-Induced | 1 | 2014 | 20 | 0.490 |
Why?
|
| Communicable Diseases | 1 | 2014 | 63 | 0.450 |
Why?
|
| Sexually Transmitted Diseases | 1 | 2015 | 97 | 0.440 |
Why?
|
| Societies, Medical | 2 | 2016 | 578 | 0.440 |
Why?
|
| Angiogenic Proteins | 2 | 2015 | 17 | 0.410 |
Why?
|
| Receptors, Cell Surface | 4 | 2010 | 288 | 0.410 |
Why?
|
| Arteries | 6 | 2008 | 179 | 0.400 |
Why?
|
| Blood Pressure | 36 | 2007 | 902 | 0.400 |
Why?
|
| Ultrasonography, Doppler | 4 | 2009 | 85 | 0.400 |
Why?
|
| Antigens, CD | 3 | 2010 | 466 | 0.390 |
Why?
|
| Biomarkers | 6 | 2015 | 1767 | 0.370 |
Why?
|
| Neovascularization, Physiologic | 2 | 2010 | 143 | 0.360 |
Why?
|
| Kidney Glomerulus | 11 | 2010 | 122 | 0.360 |
Why?
|
| Reference Values | 12 | 2017 | 661 | 0.360 |
Why?
|
| Prenatal Diagnosis | 2 | 2008 | 110 | 0.360 |
Why?
|
| Uterus | 2 | 2009 | 222 | 0.350 |
Why?
|
| Postpartum Period | 14 | 2007 | 148 | 0.340 |
Why?
|
| Counseling | 2 | 2011 | 164 | 0.340 |
Why?
|
| Polyuria | 2 | 2005 | 7 | 0.320 |
Why?
|
| Urinary Tract Infections | 6 | 2008 | 76 | 0.320 |
Why?
|
| Creatinine | 10 | 2011 | 294 | 0.300 |
Why?
|
| Periodontal Diseases | 1 | 2008 | 9 | 0.300 |
Why?
|
| Cushing Syndrome | 2 | 2007 | 24 | 0.290 |
Why?
|
| Natriuresis | 19 | 1995 | 29 | 0.290 |
Why?
|
| Podocytes | 1 | 2007 | 33 | 0.280 |
Why?
|
| Adrenocortical Carcinoma | 1 | 2007 | 11 | 0.280 |
Why?
|
| Adrenal Cortex Neoplasms | 1 | 2007 | 17 | 0.280 |
Why?
|
| Adult | 76 | 2015 | 26659 | 0.280 |
Why?
|
| Autoantibodies | 1 | 2008 | 268 | 0.270 |
Why?
|
| Biopsy | 6 | 2004 | 1183 | 0.270 |
Why?
|
| Ascorbic Acid | 1 | 2006 | 38 | 0.270 |
Why?
|
| Vitamin E | 1 | 2006 | 32 | 0.270 |
Why?
|
| Antioxidants | 3 | 2006 | 226 | 0.260 |
Why?
|
| Pregnancy in Diabetics | 9 | 2004 | 38 | 0.260 |
Why?
|
| Posture | 14 | 1986 | 124 | 0.260 |
Why?
|
| Prognosis | 13 | 2011 | 3777 | 0.260 |
Why?
|
| Asthma | 7 | 2010 | 980 | 0.260 |
Why?
|
| Kidney Transplantation | 7 | 2011 | 854 | 0.260 |
Why?
|
| Infant, Newborn | 17 | 2016 | 2487 | 0.250 |
Why?
|
| Rats | 42 | 1996 | 4040 | 0.250 |
Why?
|
| Pregnancy Trimester, Third | 14 | 2007 | 70 | 0.240 |
Why?
|
| Angiogenesis Inhibitors | 1 | 2007 | 293 | 0.240 |
Why?
|
| Thirst | 6 | 1991 | 19 | 0.240 |
Why?
|
| Hemodynamics | 12 | 2005 | 731 | 0.230 |
Why?
|
| Kidney Failure, Chronic | 3 | 2007 | 414 | 0.230 |
Why?
|
| Homeostasis | 8 | 1989 | 417 | 0.220 |
Why?
|
| Predictive Value of Tests | 8 | 2015 | 1727 | 0.220 |
Why?
|
| Animals | 55 | 2014 | 27453 | 0.220 |
Why?
|
| Gestational Age | 7 | 2011 | 328 | 0.200 |
Why?
|
| Magnesium Sulfate | 4 | 2008 | 15 | 0.200 |
Why?
|
| Obstetric Labor, Premature | 6 | 2006 | 58 | 0.200 |
Why?
|
| Desoxycorticosterone | 12 | 1989 | 18 | 0.200 |
Why?
|
| Potassium | 14 | 1987 | 258 | 0.200 |
Why?
|
| Placenta Growth Factor | 5 | 2015 | 70 | 0.200 |
Why?
|
| Kidney Calculi | 6 | 1994 | 343 | 0.190 |
Why?
|
| Risk Factors | 15 | 2013 | 5518 | 0.190 |
Why?
|
| Renal Circulation | 3 | 2003 | 48 | 0.190 |
Why?
|
| Cystinyl Aminopeptidase | 2 | 1993 | 2 | 0.190 |
Why?
|
| Vascular Resistance | 5 | 2009 | 103 | 0.170 |
Why?
|
| Risk Assessment | 5 | 2008 | 2303 | 0.170 |
Why?
|
| Endoglin | 3 | 2010 | 21 | 0.170 |
Why?
|
| Renin | 13 | 1989 | 67 | 0.170 |
Why?
|
| Progesterone | 9 | 1988 | 110 | 0.170 |
Why?
|
| Endothelium, Vascular | 5 | 2004 | 432 | 0.170 |
Why?
|
| Vasodilation | 5 | 2009 | 93 | 0.170 |
Why?
|
| Pregnancy, High-Risk | 3 | 2010 | 16 | 0.160 |
Why?
|
| Incidence | 9 | 2008 | 1598 | 0.160 |
Why?
|
| Renin-Angiotensin System | 6 | 2009 | 81 | 0.160 |
Why?
|
| Osmolar Concentration | 15 | 1998 | 182 | 0.160 |
Why?
|
| Kidney Tubules | 7 | 2010 | 92 | 0.160 |
Why?
|
| Glomerulonephritis | 7 | 1985 | 76 | 0.160 |
Why?
|
| Hypertension, Renal | 4 | 1985 | 19 | 0.150 |
Why?
|
| Placenta | 3 | 2009 | 181 | 0.150 |
Why?
|
| Calcium, Dietary | 2 | 2009 | 64 | 0.150 |
Why?
|
| Diagnosis, Differential | 7 | 2009 | 1605 | 0.150 |
Why?
|
| Smoking | 3 | 2010 | 624 | 0.150 |
Why?
|
| Beclomethasone | 2 | 2009 | 16 | 0.140 |
Why?
|
| Inhibins | 1 | 1997 | 37 | 0.140 |
Why?
|
| Theophylline | 2 | 2009 | 34 | 0.140 |
Why?
|
| Dietary Supplements | 2 | 2009 | 124 | 0.140 |
Why?
|
| Pregnancy Trimester, First | 4 | 2015 | 63 | 0.140 |
Why?
|
| Congresses as Topic | 2 | 2016 | 114 | 0.140 |
Why?
|
| Awards and Prizes | 1 | 2016 | 37 | 0.130 |
Why?
|
| History, 21st Century | 1 | 2016 | 182 | 0.130 |
Why?
|
| Dietary Proteins | 1 | 1995 | 30 | 0.130 |
Why?
|
| Amino Acid Oxidoreductases | 1 | 1995 | 9 | 0.130 |
Why?
|
| Body Water | 2 | 1994 | 35 | 0.120 |
Why?
|
| History, 20th Century | 1 | 2016 | 312 | 0.120 |
Why?
|
| Urinary Tract Physiological Phenomena | 3 | 2010 | 4 | 0.120 |
Why?
|
| Anti-Asthmatic Agents | 3 | 2004 | 77 | 0.120 |
Why?
|
| Chorionic Gonadotropin | 3 | 1991 | 72 | 0.120 |
Why?
|
| Abruptio Placentae | 5 | 2002 | 13 | 0.120 |
Why?
|
| Urinalysis | 2 | 2020 | 31 | 0.120 |
Why?
|
| Water | 3 | 1987 | 284 | 0.120 |
Why?
|
| Randomized Controlled Trials as Topic | 6 | 2006 | 834 | 0.110 |
Why?
|
| Angiogenesis Inducing Agents | 2 | 2010 | 30 | 0.110 |
Why?
|
| Diabetic Nephropathies | 3 | 2011 | 87 | 0.110 |
Why?
|
| Aspirin | 6 | 2001 | 160 | 0.110 |
Why?
|
| Rats, Inbred Strains | 15 | 1990 | 312 | 0.110 |
Why?
|
| Kidney Concentrating Ability | 7 | 1986 | 9 | 0.110 |
Why?
|
| Sodium Chloride | 8 | 1986 | 88 | 0.110 |
Why?
|
| Hydatidiform Mole | 2 | 2010 | 6 | 0.110 |
Why?
|
| Deamino Arginine Vasopressin | 1 | 1993 | 12 | 0.110 |
Why?
|
| Research Design | 2 | 2008 | 586 | 0.110 |
Why?
|
| Adolescent | 19 | 2010 | 9289 | 0.110 |
Why?
|
| Body Weight | 9 | 2010 | 452 | 0.100 |
Why?
|
| World Health Organization | 3 | 2015 | 108 | 0.100 |
Why?
|
| Diuresis | 8 | 1982 | 26 | 0.100 |
Why?
|
| Acid-Base Equilibrium | 2 | 2007 | 33 | 0.100 |
Why?
|
| Body Fluids | 2 | 1989 | 34 | 0.100 |
Why?
|
| Genome, Mitochondrial | 1 | 2012 | 28 | 0.100 |
Why?
|
| Prospective Studies | 11 | 2015 | 4305 | 0.100 |
Why?
|
| Parity | 6 | 2010 | 96 | 0.100 |
Why?
|
| Nephrotic Syndrome | 7 | 1987 | 33 | 0.100 |
Why?
|
| Chronic Disease | 9 | 2005 | 951 | 0.100 |
Why?
|
| DNA, Mitochondrial | 1 | 2012 | 189 | 0.100 |
Why?
|
| Time Factors | 13 | 2009 | 5330 | 0.100 |
Why?
|
| Metabolic Clearance Rate | 5 | 1994 | 120 | 0.100 |
Why?
|
| Regional Blood Flow | 9 | 2009 | 198 | 0.090 |
Why?
|
| Infant, Small for Gestational Age | 5 | 2002 | 29 | 0.090 |
Why?
|
| Pseudopregnancy | 2 | 1988 | 4 | 0.090 |
Why?
|
| Receptor, Macrophage Colony-Stimulating Factor | 1 | 2010 | 9 | 0.090 |
Why?
|
| Saline Solution, Hypertonic | 4 | 1988 | 24 | 0.090 |
Why?
|
| Prolactin | 4 | 1988 | 89 | 0.090 |
Why?
|
| Pregnancy, Multiple | 5 | 2000 | 37 | 0.090 |
Why?
|
| Angiotensin II | 6 | 1996 | 93 | 0.090 |
Why?
|
| Specimen Handling | 2 | 2010 | 102 | 0.090 |
Why?
|
| Body Weights and Measures | 1 | 2010 | 27 | 0.090 |
Why?
|
| Pulsatile Flow | 2 | 2008 | 50 | 0.090 |
Why?
|
| Adenosine Triphosphatases | 6 | 1977 | 154 | 0.080 |
Why?
|
| Cardiomyopathies | 3 | 1999 | 265 | 0.080 |
Why?
|
| Tobacco Smoke Pollution | 1 | 2009 | 25 | 0.080 |
Why?
|
| Hormones | 5 | 1986 | 139 | 0.080 |
Why?
|
| Receptors, Tumor Necrosis Factor, Type II | 1 | 2009 | 20 | 0.080 |
Why?
|
| Maternal Exposure | 1 | 2009 | 58 | 0.080 |
Why?
|
| Catecholamines | 4 | 1987 | 92 | 0.080 |
Why?
|
| Aminopeptidases | 1 | 1989 | 17 | 0.080 |
Why?
|
| Clinical Chemistry Tests | 1 | 2008 | 11 | 0.080 |
Why?
|
| Drinking | 2 | 1988 | 33 | 0.080 |
Why?
|
| C-Reactive Protein | 1 | 2010 | 191 | 0.080 |
Why?
|
| Diuretics | 4 | 1996 | 75 | 0.080 |
Why?
|
| Premature Birth | 2 | 2007 | 120 | 0.080 |
Why?
|
| Enalapril | 1 | 1988 | 13 | 0.080 |
Why?
|
| Labor, Obstetric | 3 | 1999 | 46 | 0.080 |
Why?
|
| Brain Edema | 1 | 2008 | 58 | 0.080 |
Why?
|
| Ultrasonography, Prenatal | 2 | 2009 | 152 | 0.080 |
Why?
|
| Hydroxyprostaglandin Dehydrogenases | 1 | 1987 | 6 | 0.070 |
Why?
|
| Follow-Up Studies | 5 | 2009 | 3658 | 0.070 |
Why?
|
| Calcium | 3 | 2006 | 1178 | 0.070 |
Why?
|
| NADP | 1 | 1987 | 45 | 0.070 |
Why?
|
| Sensitivity and Specificity | 2 | 2015 | 2015 | 0.070 |
Why?
|
| Likelihood Functions | 1 | 2008 | 251 | 0.070 |
Why?
|
| NAD | 1 | 1987 | 72 | 0.070 |
Why?
|
| Pregnancy Complications, Hematologic | 1 | 1987 | 15 | 0.070 |
Why?
|
| Anticonvulsants | 1 | 2008 | 125 | 0.070 |
Why?
|
| Fetal Death | 3 | 2002 | 57 | 0.070 |
Why?
|
| Odds Ratio | 2 | 2006 | 682 | 0.070 |
Why?
|
| Cesarean Section | 3 | 1999 | 147 | 0.070 |
Why?
|
| Ergolines | 4 | 1987 | 8 | 0.070 |
Why?
|
| Oxidative Stress | 3 | 2004 | 457 | 0.070 |
Why?
|
| Membrane Proteins | 1 | 2013 | 1226 | 0.070 |
Why?
|
| Relaxin | 1 | 2006 | 8 | 0.070 |
Why?
|
| Protein-Tyrosine Kinases | 1 | 2008 | 306 | 0.070 |
Why?
|
| Cerebrovascular Circulation | 1 | 2008 | 229 | 0.070 |
Why?
|
| Hydrocortisone | 6 | 1980 | 301 | 0.070 |
Why?
|
| Pregnancy Trimester, Second | 5 | 2015 | 70 | 0.070 |
Why?
|
| Fatty Liver | 1 | 1987 | 96 | 0.070 |
Why?
|
| Disease Progression | 2 | 2009 | 1462 | 0.070 |
Why?
|
| Atrial Function | 1 | 1986 | 19 | 0.070 |
Why?
|
| Atrial Natriuretic Factor | 1 | 1986 | 39 | 0.070 |
Why?
|
| Insulin | 5 | 1986 | 1148 | 0.070 |
Why?
|
| Gonadal Steroid Hormones | 1 | 1986 | 50 | 0.070 |
Why?
|
| Headache | 1 | 2006 | 73 | 0.070 |
Why?
|
| Spirometry | 1 | 2006 | 66 | 0.060 |
Why?
|
| Fetal Growth Retardation | 1 | 2006 | 68 | 0.060 |
Why?
|
| Mineralocorticoids | 3 | 1980 | 7 | 0.060 |
Why?
|
| Echoencephalography | 1 | 1985 | 12 | 0.060 |
Why?
|
| Treatment Failure | 1 | 2006 | 278 | 0.060 |
Why?
|
| Infant, Premature | 4 | 2002 | 298 | 0.060 |
Why?
|
| Models, Biological | 3 | 2009 | 1762 | 0.060 |
Why?
|
| Abdominal Pain | 1 | 2006 | 142 | 0.060 |
Why?
|
| Anemia, Sickle Cell | 1 | 1987 | 144 | 0.060 |
Why?
|
| Blood Pressure Monitoring, Ambulatory | 1 | 2004 | 28 | 0.060 |
Why?
|
| Kallikreins | 1 | 2004 | 47 | 0.060 |
Why?
|
| Ovary | 1 | 1986 | 262 | 0.060 |
Why?
|
| Maternal Health Services | 1 | 2004 | 16 | 0.060 |
Why?
|
| Dextrans | 3 | 2003 | 79 | 0.060 |
Why?
|
| Inulin | 8 | 2003 | 17 | 0.060 |
Why?
|
| Heart Rate | 7 | 2005 | 498 | 0.060 |
Why?
|
| Adrenocorticotropic Hormone | 6 | 1980 | 131 | 0.060 |
Why?
|
| Comorbidity | 1 | 2008 | 952 | 0.060 |
Why?
|
| Male | 24 | 2015 | 42438 | 0.060 |
Why?
|
| Reproduction | 1 | 2005 | 199 | 0.060 |
Why?
|
| Bronchodilator Agents | 1 | 2004 | 66 | 0.060 |
Why?
|
| Hypothyroidism | 3 | 1975 | 241 | 0.060 |
Why?
|
| Seizures | 1 | 2006 | 307 | 0.060 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2005 | 405 | 0.050 |
Why?
|
| Omentum | 2 | 2001 | 74 | 0.050 |
Why?
|
| Hematoma | 1 | 2004 | 108 | 0.050 |
Why?
|
| Cohort Studies | 5 | 2011 | 2876 | 0.050 |
Why?
|
| Receptors, Dopamine | 3 | 1987 | 37 | 0.050 |
Why?
|
| Ventricular Function, Left | 3 | 1999 | 607 | 0.050 |
Why?
|
| Proteins | 3 | 2005 | 786 | 0.050 |
Why?
|
| Blood | 2 | 1985 | 69 | 0.050 |
Why?
|
| Norepinephrine | 6 | 1993 | 172 | 0.050 |
Why?
|
| Maternal Welfare | 1 | 2001 | 9 | 0.050 |
Why?
|
| Hemorrhage | 1 | 2004 | 284 | 0.050 |
Why?
|
| Extracellular Space | 3 | 1986 | 92 | 0.050 |
Why?
|
| Organ Transplantation | 1 | 2005 | 280 | 0.050 |
Why?
|
| Antibodies, Antiphospholipid | 1 | 2001 | 10 | 0.050 |
Why?
|
| Cognition | 1 | 2006 | 578 | 0.050 |
Why?
|
| Ethics, Medical | 1 | 2004 | 306 | 0.050 |
Why?
|
| Pentobarbital | 2 | 1986 | 20 | 0.050 |
Why?
|
| Pyelonephritis | 4 | 1985 | 9 | 0.050 |
Why?
|
| Nitric Oxide Synthase | 3 | 1996 | 126 | 0.050 |
Why?
|
| Informed Consent | 1 | 2004 | 275 | 0.050 |
Why?
|
| Kidney Function Tests | 7 | 1977 | 115 | 0.050 |
Why?
|
| Prostaglandins E | 4 | 1987 | 19 | 0.050 |
Why?
|
| Amino Acids | 1 | 2002 | 246 | 0.050 |
Why?
|
| Brain | 3 | 2008 | 2292 | 0.050 |
Why?
|
| Mutation | 1 | 2012 | 4158 | 0.050 |
Why?
|
| Double-Blind Method | 5 | 2006 | 1708 | 0.050 |
Why?
|
| Dinoprostone | 4 | 1989 | 70 | 0.040 |
Why?
|
| Connexin 43 | 1 | 2001 | 94 | 0.040 |
Why?
|
| Dopamine | 3 | 1995 | 276 | 0.040 |
Why?
|
| Streptococcal Infections | 1 | 1980 | 56 | 0.040 |
Why?
|
| Tocolytic Agents | 2 | 2006 | 8 | 0.040 |
Why?
|
| Nephrons | 1 | 1980 | 17 | 0.040 |
Why?
|
| Hypertension, Renovascular | 1 | 1980 | 12 | 0.040 |
Why?
|
| Delivery, Obstetric | 3 | 1993 | 120 | 0.040 |
Why?
|
| Uric Acid | 5 | 1972 | 136 | 0.040 |
Why?
|
| Thiopental | 1 | 1979 | 15 | 0.040 |
Why?
|
| Mass Screening | 1 | 2004 | 642 | 0.040 |
Why?
|
| Pulmonary Edema | 1 | 1999 | 50 | 0.040 |
Why?
|
| Anesthesia, Epidural | 1 | 1999 | 32 | 0.040 |
Why?
|
| Maternal-Fetal Exchange | 4 | 2003 | 77 | 0.040 |
Why?
|
| Microcirculation | 2 | 1996 | 104 | 0.040 |
Why?
|
| Thromboxane B2 | 1 | 1998 | 11 | 0.040 |
Why?
|
| Renal Insufficiency | 1 | 1999 | 98 | 0.040 |
Why?
|
| Cardiovascular Physiological Phenomena | 2 | 1997 | 36 | 0.040 |
Why?
|
| Infusions, Parenteral | 3 | 1985 | 51 | 0.040 |
Why?
|
| Vasoconstriction | 2 | 1996 | 92 | 0.040 |
Why?
|
| Cyclooxygenase Inhibitors | 1 | 1998 | 39 | 0.040 |
Why?
|
| Anesthesia, General | 1 | 1979 | 116 | 0.040 |
Why?
|
| Angiotensin-Converting Enzyme Inhibitors | 3 | 1996 | 91 | 0.040 |
Why?
|
| Adaptation, Physiological | 3 | 1995 | 314 | 0.040 |
Why?
|
| Hypertrophy | 2 | 1994 | 67 | 0.040 |
Why?
|
| Young Adult | 4 | 2012 | 6354 | 0.040 |
Why?
|
| Nephrosis | 1 | 1977 | 3 | 0.040 |
Why?
|
| Autonomic Nerve Block | 2 | 1994 | 3 | 0.040 |
Why?
|
| Kidney Tubules, Proximal | 1 | 1978 | 60 | 0.040 |
Why?
|
| Immunohistochemistry | 2 | 2010 | 1793 | 0.040 |
Why?
|
| Myocardial Contraction | 2 | 1997 | 252 | 0.040 |
Why?
|
| Infusions, Intravenous | 2 | 1989 | 416 | 0.040 |
Why?
|
| Aminohippuric Acids | 6 | 1976 | 7 | 0.040 |
Why?
|
| Thyroid Hormones | 4 | 1980 | 329 | 0.040 |
Why?
|
| Vasomotor System | 1 | 1997 | 13 | 0.040 |
Why?
|
| Hyperthyroidism | 2 | 1975 | 75 | 0.040 |
Why?
|
| Diabetes Mellitus, Type 1 | 2 | 2000 | 565 | 0.040 |
Why?
|
| Nitric Oxide | 3 | 1998 | 279 | 0.040 |
Why?
|
| Activins | 1 | 1997 | 26 | 0.040 |
Why?
|
| Electrolytes | 1 | 1977 | 52 | 0.040 |
Why?
|
| Mestranol | 1 | 1976 | 4 | 0.030 |
Why?
|
| Hypophysectomy | 1 | 1976 | 27 | 0.030 |
Why?
|
| Norethindrone | 1 | 1976 | 12 | 0.030 |
Why?
|
| Nephrology | 1 | 1997 | 42 | 0.030 |
Why?
|
| Adrenergic alpha-Agonists | 1 | 1996 | 33 | 0.030 |
Why?
|
| Administration, Inhalation | 2 | 2009 | 192 | 0.030 |
Why?
|
| Adrenalectomy | 1 | 1976 | 45 | 0.030 |
Why?
|
| United States | 6 | 2010 | 7033 | 0.030 |
Why?
|
| Abortion, Septic | 1 | 1976 | 3 | 0.030 |
Why?
|
| Calcium Channel Blockers | 1 | 1996 | 121 | 0.030 |
Why?
|
| Anuria | 1 | 1976 | 6 | 0.030 |
Why?
|
| Estradiol | 2 | 1988 | 250 | 0.030 |
Why?
|
| Multicenter Studies as Topic | 3 | 2002 | 164 | 0.030 |
Why?
|
| Splanchnic Circulation | 1 | 1995 | 14 | 0.030 |
Why?
|
| Thyroid Gland | 2 | 1975 | 280 | 0.030 |
Why?
|
| Rats, Brattleboro | 3 | 1987 | 3 | 0.030 |
Why?
|
| Hypotonic Solutions | 3 | 1971 | 8 | 0.030 |
Why?
|
| Adrenergic beta-Antagonists | 1 | 1996 | 105 | 0.030 |
Why?
|
| Switzerland | 1 | 2015 | 17 | 0.030 |
Why?
|
| Urea | 2 | 1981 | 59 | 0.030 |
Why?
|
| Kenya | 1 | 2015 | 7 | 0.030 |
Why?
|
| Argentina | 1 | 2015 | 13 | 0.030 |
Why?
|
| Vasodilator Agents | 1 | 1996 | 145 | 0.030 |
Why?
|
| Colombia | 1 | 2015 | 12 | 0.030 |
Why?
|
| Rodent Diseases | 1 | 1976 | 34 | 0.030 |
Why?
|
| Peru | 1 | 2015 | 23 | 0.030 |
Why?
|
| Femur | 1 | 1996 | 112 | 0.030 |
Why?
|
| Thailand | 1 | 2015 | 57 | 0.030 |
Why?
|
| Italy | 1 | 2015 | 108 | 0.030 |
Why?
|
| India | 1 | 2015 | 125 | 0.030 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 2 | 2010 | 373 | 0.030 |
Why?
|
| Cardiovascular System | 3 | 1994 | 63 | 0.030 |
Why?
|
| Plasma Volume | 2 | 1985 | 5 | 0.030 |
Why?
|
| Epinephrine | 4 | 1989 | 89 | 0.030 |
Why?
|
| Forced Expiratory Volume | 2 | 2006 | 125 | 0.030 |
Why?
|
| Hemolytic-Uremic Syndrome | 1 | 1994 | 9 | 0.030 |
Why?
|
| Kidney Medulla | 3 | 1983 | 80 | 0.030 |
Why?
|
| Endothelium | 1 | 1994 | 57 | 0.030 |
Why?
|
| Glomerulosclerosis, Focal Segmental | 1 | 1994 | 35 | 0.030 |
Why?
|
| Diabetes, Gestational | 1 | 1994 | 41 | 0.030 |
Why?
|
| Lupus Erythematosus, Systemic | 3 | 1985 | 212 | 0.030 |
Why?
|
| Rats, Mutant Strains | 2 | 1985 | 23 | 0.030 |
Why?
|
| Phospholipids | 3 | 1980 | 112 | 0.030 |
Why?
|
| Clostridium Infections | 1 | 1976 | 125 | 0.030 |
Why?
|
| Clinical Trials as Topic | 2 | 1996 | 1131 | 0.030 |
Why?
|
| Autonomic Nervous System | 1 | 1993 | 65 | 0.030 |
Why?
|
| Phenylephrine | 4 | 1996 | 36 | 0.030 |
Why?
|
| Factor VIII | 1 | 1993 | 7 | 0.030 |
Why?
|
| Albuminuria | 3 | 2003 | 48 | 0.030 |
Why?
|
| Terbutaline | 1 | 1993 | 16 | 0.030 |
Why?
|
| Case-Control Studies | 2 | 2010 | 1860 | 0.030 |
Why?
|
| Retrospective Studies | 6 | 2010 | 9097 | 0.030 |
Why?
|
| Education, Medical, Graduate | 1 | 1997 | 400 | 0.030 |
Why?
|
| von Willebrand Factor | 1 | 1993 | 37 | 0.030 |
Why?
|
| Nitroarginine | 3 | 1998 | 16 | 0.030 |
Why?
|
| Recurrence | 2 | 2010 | 1143 | 0.030 |
Why?
|
| Polyethylene Glycols | 2 | 1986 | 360 | 0.030 |
Why?
|
| NADH Dehydrogenase | 1 | 2012 | 22 | 0.030 |
Why?
|
| Fludrocortisone | 1 | 1972 | 2 | 0.030 |
Why?
|
| Umbilical Cord | 1 | 2012 | 40 | 0.030 |
Why?
|
| In Vitro Techniques | 2 | 1987 | 996 | 0.030 |
Why?
|
| Trophoblasts | 1 | 2012 | 33 | 0.030 |
Why?
|
| Curriculum | 1 | 1997 | 570 | 0.030 |
Why?
|
| Magnesium | 3 | 1987 | 178 | 0.030 |
Why?
|
| Acetylcholine | 3 | 1998 | 177 | 0.030 |
Why?
|
| Acute Disease | 2 | 1987 | 841 | 0.030 |
Why?
|
| Rats, Sprague-Dawley | 4 | 1996 | 1237 | 0.030 |
Why?
|
| Compliance | 2 | 2005 | 21 | 0.020 |
Why?
|
| Disease Models, Animal | 2 | 1977 | 2375 | 0.020 |
Why?
|
| Reagent Strips | 1 | 2011 | 4 | 0.020 |
Why?
|
| Urine Specimen Collection | 1 | 2011 | 4 | 0.020 |
Why?
|
| Research | 2 | 2003 | 251 | 0.020 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2000 | 1180 | 0.020 |
Why?
|
| Hyperemesis Gravidarum | 1 | 1971 | 1 | 0.020 |
Why?
|
| Microsomes | 4 | 1977 | 35 | 0.020 |
Why?
|
| Captopril | 3 | 1990 | 20 | 0.020 |
Why?
|
| Uremia | 3 | 1980 | 14 | 0.020 |
Why?
|
| Prenatal Care | 2 | 2000 | 77 | 0.020 |
Why?
|
| Immersion | 1 | 1990 | 21 | 0.020 |
Why?
|
| Haplotypes | 1 | 2012 | 636 | 0.020 |
Why?
|
| p-Aminohippuric Acid | 2 | 2003 | 4 | 0.020 |
Why?
|
| Maternal Age | 1 | 2010 | 45 | 0.020 |
Why?
|
| Intestinal Obstruction | 1 | 1971 | 89 | 0.020 |
Why?
|
| Platelet Endothelial Cell Adhesion Molecule-1 | 1 | 2010 | 46 | 0.020 |
Why?
|
| Hyponatremia | 1 | 1970 | 28 | 0.020 |
Why?
|
| Laser-Doppler Flowmetry | 1 | 2009 | 20 | 0.020 |
Why?
|
| Amyloidosis | 1 | 1971 | 130 | 0.020 |
Why?
|
| Body Height | 1 | 2010 | 100 | 0.020 |
Why?
|
| Infant Mortality | 2 | 1998 | 59 | 0.020 |
Why?
|
| Neurophysins | 1 | 1989 | 4 | 0.020 |
Why?
|
| Head | 1 | 2010 | 137 | 0.020 |
Why?
|
| Adrenal Cortex Hormones | 2 | 2004 | 270 | 0.020 |
Why?
|
| Chi-Square Distribution | 1 | 2010 | 358 | 0.020 |
Why?
|
| Kinetics | 3 | 1988 | 1534 | 0.020 |
Why?
|
| Sequence Analysis, DNA | 1 | 2012 | 868 | 0.020 |
Why?
|
| Insurance, Health | 1 | 2010 | 163 | 0.020 |
Why?
|
| ROC Curve | 1 | 2011 | 777 | 0.020 |
Why?
|
| Estrogens | 3 | 1977 | 200 | 0.020 |
Why?
|
| Choline | 2 | 1980 | 24 | 0.020 |
Why?
|
| Immunoglobulin M | 2 | 2001 | 163 | 0.020 |
Why?
|
| Heparinoids | 2 | 1980 | 4 | 0.020 |
Why?
|
| Hematocrit | 1 | 1988 | 68 | 0.020 |
Why?
|
| Dobutamine | 2 | 1999 | 61 | 0.020 |
Why?
|
| Organ Size | 2 | 1980 | 370 | 0.020 |
Why?
|
| Calcium Oxalate | 1 | 1989 | 186 | 0.020 |
Why?
|
| Graft Survival | 1 | 1992 | 902 | 0.020 |
Why?
|
| Magnesium Compounds | 1 | 1987 | 7 | 0.020 |
Why?
|
| Administration, Oral | 1 | 2009 | 666 | 0.020 |
Why?
|
| Acute Kidney Injury | 2 | 1987 | 316 | 0.020 |
Why?
|
| Parathyroid Hormone | 3 | 1980 | 217 | 0.020 |
Why?
|
| Chicago | 1 | 2012 | 1430 | 0.020 |
Why?
|
| Anesthesia | 2 | 1986 | 166 | 0.020 |
Why?
|
| Epoprostenol | 1 | 1987 | 46 | 0.020 |
Why?
|
| Hyperkalemia | 1 | 1987 | 13 | 0.020 |
Why?
|
| Drug Therapy, Combination | 1 | 2009 | 782 | 0.020 |
Why?
|
| Collagen Diseases | 2 | 1978 | 3 | 0.020 |
Why?
|
| Diet | 3 | 1977 | 443 | 0.020 |
Why?
|
| Edema | 2 | 1981 | 70 | 0.020 |
Why?
|
| Colic | 1 | 1987 | 7 | 0.020 |
Why?
|
| Polycystic Kidney Diseases | 2 | 1978 | 20 | 0.020 |
Why?
|
| Quinpirole | 4 | 1987 | 7 | 0.020 |
Why?
|
| Phosphates | 1 | 1987 | 161 | 0.020 |
Why?
|
| Immunoglobulin G | 2 | 2001 | 468 | 0.020 |
Why?
|
| Estrus | 1 | 1986 | 43 | 0.020 |
Why?
|
| Kidney Cortex | 2 | 1977 | 34 | 0.020 |
Why?
|
| Body Fluid Compartments | 1 | 1986 | 1 | 0.020 |
Why?
|
| Abortion, Induced | 2 | 1982 | 137 | 0.020 |
Why?
|
| Pulse | 1 | 1986 | 17 | 0.020 |
Why?
|
| Potassium Chloride | 2 | 1996 | 86 | 0.020 |
Why?
|
| Nephrectomy | 3 | 1987 | 291 | 0.020 |
Why?
|
| Biological Assay | 1 | 1986 | 79 | 0.020 |
Why?
|
| Physical Exertion | 1 | 1986 | 38 | 0.020 |
Why?
|
| Ovariectomy | 1 | 1986 | 82 | 0.020 |
Why?
|
| Blood Flow Velocity | 2 | 1997 | 200 | 0.020 |
Why?
|
| Circadian Rhythm | 2 | 1980 | 304 | 0.020 |
Why?
|
| Postoperative Complications | 1 | 1976 | 2290 | 0.020 |
Why?
|
| Ureteral Calculi | 1 | 1985 | 10 | 0.020 |
Why?
|
| Osmotic Pressure | 1 | 1985 | 21 | 0.020 |
Why?
|
| Colloids | 1 | 1985 | 26 | 0.020 |
Why?
|
| Obstetric Labor Complications | 1 | 1985 | 34 | 0.020 |
Why?
|
| Risk | 2 | 1978 | 655 | 0.020 |
Why?
|
| Biopsy, Needle | 2 | 1976 | 231 | 0.020 |
Why?
|
| Polyarteritis Nodosa | 1 | 1984 | 7 | 0.020 |
Why?
|
| Lipid Metabolism | 2 | 1983 | 201 | 0.020 |
Why?
|
| Congenital Abnormalities | 1 | 1984 | 64 | 0.010 |
Why?
|
| Medical Laboratory Science | 1 | 2004 | 7 | 0.010 |
Why?
|
| Urinary Diversion | 1 | 1984 | 42 | 0.010 |
Why?
|
| Scleroderma, Systemic | 1 | 1984 | 53 | 0.010 |
Why?
|
| Medically Underserved Area | 1 | 2004 | 27 | 0.010 |
Why?
|
| Monitoring, Physiologic | 1 | 1986 | 265 | 0.010 |
Why?
|
| Drug Tolerance | 1 | 1984 | 64 | 0.010 |
Why?
|
| Pilot Projects | 1 | 2007 | 870 | 0.010 |
Why?
|
| Inflammation | 1 | 2010 | 975 | 0.010 |
Why?
|
| Memory | 1 | 2006 | 220 | 0.010 |
Why?
|
| Cardiac Output | 2 | 1994 | 155 | 0.010 |
Why?
|
| Developing Countries | 1 | 2004 | 78 | 0.010 |
Why?
|
| Proline | 1 | 1983 | 55 | 0.010 |
Why?
|
| Multivariate Analysis | 1 | 2006 | 984 | 0.010 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2012 | 2354 | 0.010 |
Why?
|
| Dexamethasone | 3 | 1978 | 342 | 0.010 |
Why?
|
| Hospitals, University | 1 | 2004 | 196 | 0.010 |
Why?
|
| Ultrafiltration | 1 | 2003 | 13 | 0.010 |
Why?
|
| Transcortin | 2 | 1980 | 2 | 0.010 |
Why?
|
| Combined Modality Therapy | 1 | 1987 | 1705 | 0.010 |
Why?
|
| Domperidone | 3 | 1987 | 8 | 0.010 |
Why?
|
| Erythrocytes | 1 | 1984 | 254 | 0.010 |
Why?
|
| Respiratory Function Tests | 1 | 2003 | 139 | 0.010 |
Why?
|
| Arginine | 2 | 1995 | 138 | 0.010 |
Why?
|
| Biological Transport, Active | 2 | 1973 | 102 | 0.010 |
Why?
|
| Ganglionic Blockers | 2 | 1993 | 2 | 0.010 |
Why?
|
| Receptors, Dopamine D2 | 3 | 1987 | 57 | 0.010 |
Why?
|
| Drug Interactions | 2 | 1986 | 244 | 0.010 |
Why?
|
| Corticosterone | 2 | 1976 | 35 | 0.010 |
Why?
|
| National Institutes of Health (U.S.) | 1 | 2003 | 125 | 0.010 |
Why?
|
| Abortion, Spontaneous | 1 | 1982 | 66 | 0.010 |
Why?
|
| Infant, Newborn, Diseases | 1 | 1982 | 111 | 0.010 |
Why?
|
| Spinal Cord | 1 | 1983 | 255 | 0.010 |
Why?
|
| Phenoxybenzamine | 3 | 1987 | 15 | 0.010 |
Why?
|
| Drinking Behavior | 1 | 1981 | 13 | 0.010 |
Why?
|
| Attention | 1 | 2006 | 395 | 0.010 |
Why?
|
| Breast Feeding | 1 | 1982 | 102 | 0.010 |
Why?
|
| Antibodies, Anticardiolipin | 1 | 2001 | 5 | 0.010 |
Why?
|
| Medical Records | 1 | 2002 | 120 | 0.010 |
Why?
|
| Surveys and Questionnaires | 1 | 2009 | 2641 | 0.010 |
Why?
|
| Glucagon | 2 | 1980 | 111 | 0.010 |
Why?
|
| HELLP Syndrome | 1 | 2000 | 8 | 0.010 |
Why?
|
| Health Services Accessibility | 1 | 2004 | 431 | 0.010 |
Why?
|
| Fluorescent Antibody Technique | 1 | 1981 | 323 | 0.010 |
Why?
|
| Desoximetasone | 1 | 1980 | 1 | 0.010 |
Why?
|
| Angiotensins | 1 | 1980 | 5 | 0.010 |
Why?
|
| Chromatography, Gel | 1 | 1980 | 103 | 0.010 |
Why?
|
| Radioimmunoassay | 1 | 1980 | 155 | 0.010 |
Why?
|
| Transplantation, Homologous | 1 | 1982 | 995 | 0.010 |
Why?
|
| Fetal Distress | 1 | 1999 | 11 | 0.010 |
Why?
|
| Twins | 1 | 2000 | 65 | 0.010 |
Why?
|
| Echocardiography | 2 | 1997 | 939 | 0.010 |
Why?
|
| Blood Coagulation Disorders | 1 | 1981 | 66 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 1998 | 1928 | 0.010 |
Why?
|
| Iodine Radioisotopes | 1 | 1980 | 134 | 0.010 |
Why?
|
| Lung | 1 | 2006 | 1270 | 0.010 |
Why?
|
| Blotting, Western | 1 | 2001 | 793 | 0.010 |
Why?
|
| Safety | 1 | 1999 | 145 | 0.010 |
Why?
|
| Cardiotonic Agents | 1 | 1999 | 89 | 0.010 |
Why?
|
| Thrombocytopenia | 1 | 2000 | 187 | 0.010 |
Why?
|
| Fetal Blood | 2 | 1976 | 93 | 0.010 |
Why?
|
| Platelet Aggregation Inhibitors | 1 | 2000 | 145 | 0.010 |
Why?
|
| Survival Rate | 1 | 2003 | 1886 | 0.010 |
Why?
|
| Fetal Monitoring | 1 | 1978 | 19 | 0.010 |
Why?
|
| Placebos | 1 | 1998 | 211 | 0.010 |
Why?
|
| Bradykinin | 1 | 1998 | 46 | 0.010 |
Why?
|
| Enzyme Inhibitors | 2 | 1996 | 642 | 0.010 |
Why?
|
| Hyperparathyroidism | 1 | 1977 | 67 | 0.010 |
Why?
|
| Parathyroid Glands | 1 | 1977 | 74 | 0.010 |
Why?
|
| Physician Executives | 1 | 1997 | 22 | 0.010 |
Why?
|
| Biological Transport | 2 | 1969 | 401 | 0.010 |
Why?
|
| Education | 1 | 1997 | 58 | 0.010 |
Why?
|
| Calcitonin | 1 | 1977 | 38 | 0.010 |
Why?
|
| Adenoma, Chromophobe | 1 | 1976 | 3 | 0.010 |
Why?
|
| Adrenergic beta-Agonists | 1 | 1997 | 74 | 0.010 |
Why?
|
| Growth Hormone | 1 | 1977 | 96 | 0.010 |
Why?
|
| Models, Cardiovascular | 1 | 1997 | 107 | 0.010 |
Why?
|
| Ultrasonography | 1 | 1999 | 711 | 0.010 |
Why?
|
| Graft Rejection | 1 | 1982 | 1072 | 0.010 |
Why?
|
| Metoclopramide | 2 | 1986 | 16 | 0.010 |
Why?
|
| Adenylyl Cyclases | 1 | 1977 | 100 | 0.010 |
Why?
|
| Cardiovascular Diseases | 1 | 2003 | 714 | 0.010 |
Why?
|
| Abortion, Criminal | 1 | 1976 | 1 | 0.010 |
Why?
|
| Lysine Carboxypeptidase | 1 | 1976 | 2 | 0.010 |
Why?
|
| alpha-Macroglobulins | 1 | 1976 | 3 | 0.010 |
Why?
|
| Kidney Tubular Necrosis, Acute | 1 | 1976 | 9 | 0.010 |
Why?
|
| Angiotensinogen | 1 | 1976 | 5 | 0.010 |
Why?
|
| Complement C4 | 1 | 1976 | 9 | 0.010 |
Why?
|
| Pituitary Neoplasms | 1 | 1976 | 69 | 0.010 |
Why?
|
| Complement C3 | 1 | 1976 | 58 | 0.010 |
Why?
|
| Permeability | 1 | 1996 | 138 | 0.010 |
Why?
|
| Adenosine Triphosphate | 1 | 1977 | 316 | 0.010 |
Why?
|
| Rabbits | 1 | 1977 | 639 | 0.010 |
Why?
|
| Dactinomycin | 1 | 1975 | 36 | 0.010 |
Why?
|
| Aorta | 1 | 1997 | 289 | 0.010 |
Why?
|
| Cycloheximide | 1 | 1975 | 56 | 0.010 |
Why?
|
| Fibrin | 1 | 1976 | 86 | 0.010 |
Why?
|
| Ouabain | 1 | 1975 | 24 | 0.010 |
Why?
|
| Immunoglobulin A | 1 | 1976 | 83 | 0.010 |
Why?
|
| Blood Vessels | 1 | 1995 | 94 | 0.010 |
Why?
|
| Vasoconstrictor Agents | 1 | 1995 | 56 | 0.010 |
Why?
|
| Guinea Pigs | 1 | 1975 | 172 | 0.010 |
Why?
|
| Veins | 1 | 1976 | 95 | 0.010 |
Why?
|
| Immunoglobulin E | 1 | 1976 | 145 | 0.010 |
Why?
|
| Blood Coagulation | 1 | 1975 | 91 | 0.010 |
Why?
|
| Cerebral Hemorrhage | 1 | 1998 | 341 | 0.010 |
Why?
|
| Iodides | 1 | 1975 | 18 | 0.010 |
Why?
|
| Curettage | 1 | 1974 | 14 | 0.010 |
Why?
|
| Minerals | 1 | 1975 | 22 | 0.010 |
Why?
|
| Epilepsy, Tonic-Clonic | 1 | 1974 | 8 | 0.010 |
Why?
|
| Fasting | 1 | 1975 | 162 | 0.010 |
Why?
|
| Contraceptives, Oral | 1 | 1974 | 46 | 0.010 |
Why?
|
| Hypercalcemia | 1 | 1975 | 63 | 0.010 |
Why?
|
| Diabetes Complications | 1 | 1976 | 170 | 0.010 |
Why?
|
| Reflex | 1 | 1994 | 80 | 0.010 |
Why?
|
| Adrenal Medulla | 2 | 1986 | 48 | 0.010 |
Why?
|
| Dehydration | 2 | 1984 | 20 | 0.010 |
Why?
|
| RNA | 1 | 1978 | 581 | 0.010 |
Why?
|
| Plasma Substitutes | 1 | 1973 | 9 | 0.010 |
Why?
|
| Kidney Cortex Necrosis | 1 | 1973 | 1 | 0.010 |
Why?
|
| Bacteriuria | 1 | 1973 | 10 | 0.010 |
Why?
|
| Iodine Isotopes | 1 | 1973 | 18 | 0.010 |
Why?
|
| Nutritional Requirements | 1 | 1973 | 17 | 0.010 |
Why?
|
| Nucleotidases | 1 | 1973 | 4 | 0.010 |
Why?
|
| Injections, Intraventricular | 2 | 1983 | 19 | 0.010 |
Why?
|
| Glucose-6-Phosphatase | 1 | 1973 | 8 | 0.010 |
Why?
|
| Immunosuppressive Agents | 1 | 1998 | 976 | 0.010 |
Why?
|
| Dermatomyositis | 1 | 1973 | 18 | 0.010 |
Why?
|
| Hydrogen-Ion Concentration | 2 | 1989 | 503 | 0.010 |
Why?
|
| Methylprednisolone | 1 | 1973 | 64 | 0.010 |
Why?
|
| Depression, Chemical | 1 | 1972 | 27 | 0.010 |
Why?
|
| Glycosuria | 1 | 1972 | 4 | 0.010 |
Why?
|
| Thyroidectomy | 1 | 1973 | 171 | 0.010 |
Why?
|
| Fetal Diseases | 1 | 1972 | 82 | 0.010 |
Why?
|
| Triiodothyronine | 1 | 1973 | 344 | 0.010 |
Why?
|
| Emergencies | 1 | 1972 | 122 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2004 | 8200 | 0.010 |
Why?
|
| Trichlormethiazide | 1 | 1970 | 9 | 0.010 |
Why?
|
| omega-N-Methylarginine | 1 | 1990 | 17 | 0.010 |
Why?
|
| Sexual Abstinence | 1 | 1990 | 10 | 0.010 |
Why?
|
| Diet Therapy | 1 | 1970 | 20 | 0.010 |
Why?
|
| Phenobarbital | 1 | 1970 | 33 | 0.010 |
Why?
|
| Dilatation | 1 | 1970 | 48 | 0.010 |
Why?
|
| Saralasin | 1 | 1990 | 2 | 0.010 |
Why?
|
| Acrylates | 1 | 1970 | 18 | 0.010 |
Why?
|
| Electrophoresis | 1 | 1970 | 55 | 0.010 |
Why?
|
| Adrenergic alpha-Antagonists | 1 | 1990 | 31 | 0.010 |
Why?
|
| Amides | 1 | 1970 | 53 | 0.010 |
Why?
|
| Gels | 1 | 1970 | 49 | 0.010 |
Why?
|
| Diet, Sodium-Restricted | 1 | 1970 | 6 | 0.010 |
Why?
|
| Sodium, Dietary | 1 | 1989 | 8 | 0.010 |
Why?
|
| Alkalies | 1 | 1989 | 8 | 0.010 |
Why?
|
| Struvite | 1 | 1987 | 7 | 0.000 |
Why?
|
| Proinsulin | 2 | 1980 | 124 | 0.000 |
Why?
|
| Absorption | 1 | 1967 | 25 | 0.000 |
Why?
|
| Spironolactone | 1 | 1967 | 12 | 0.000 |
Why?
|
| Urethane | 1 | 1986 | 5 | 0.000 |
Why?
|
| Methoxamine | 1 | 1986 | 3 | 0.000 |
Why?
|
| Hexamethonium Compounds | 1 | 1986 | 6 | 0.000 |
Why?
|
| Hexamethonium | 1 | 1986 | 4 | 0.000 |
Why?
|
| Drug Implants | 1 | 1986 | 34 | 0.000 |
Why?
|
| Dogs | 1 | 1967 | 704 | 0.000 |
Why?
|
| Hypothalamus | 1 | 1986 | 79 | 0.000 |
Why?
|
| Drug Combinations | 1 | 1986 | 203 | 0.000 |
Why?
|
| Basal Metabolism | 1 | 1985 | 19 | 0.000 |
Why?
|
| Peptides | 2 | 1980 | 649 | 0.000 |
Why?
|
| Pituitary Gland | 1 | 1985 | 119 | 0.000 |
Why?
|
| Perfusion | 1 | 1986 | 237 | 0.000 |
Why?
|
| Heterozygote | 1 | 1985 | 373 | 0.000 |
Why?
|
| Sympathectomy, Chemical | 1 | 1983 | 6 | 0.000 |
Why?
|
| Hydroxydopamines | 1 | 1983 | 7 | 0.000 |
Why?
|
| Oxidopamine | 1 | 1983 | 8 | 0.000 |
Why?
|
| Peripheral Nerves | 1 | 1983 | 37 | 0.000 |
Why?
|
| Brain Chemistry | 1 | 1983 | 122 | 0.000 |
Why?
|
| Denervation | 1 | 1982 | 24 | 0.000 |
Why?
|
| Central Nervous System | 1 | 1983 | 153 | 0.000 |
Why?
|
| Sympathetic Nervous System | 1 | 1982 | 96 | 0.000 |
Why?
|
| Apgar Score | 1 | 1982 | 13 | 0.000 |
Why?
|
| Water Deprivation | 1 | 1982 | 1 | 0.000 |
Why?
|
| Nephrosclerosis | 1 | 1982 | 5 | 0.000 |
Why?
|
| Mice | 1 | 1976 | 11812 | 0.000 |
Why?
|
| Carbohydrate Metabolism | 1 | 1980 | 29 | 0.000 |
Why?
|
| Biotransformation | 1 | 1980 | 49 | 0.000 |
Why?
|
| Half-Life | 1 | 1980 | 97 | 0.000 |
Why?
|
| Dihydroxycholecalciferols | 1 | 1980 | 10 | 0.000 |
Why?
|
| Clomiphene | 1 | 1980 | 18 | 0.000 |
Why?
|
| Follicle Stimulating Hormone | 1 | 1980 | 147 | 0.000 |
Why?
|
| Luteinizing Hormone | 1 | 1980 | 167 | 0.000 |
Why?
|
| C-Peptide | 1 | 1980 | 179 | 0.000 |
Why?
|
| Gonadotropin-Releasing Hormone | 1 | 1980 | 106 | 0.000 |
Why?
|
| Injections, Intramuscular | 1 | 1979 | 64 | 0.000 |
Why?
|
| Sexual Dysfunction, Physiological | 1 | 1980 | 69 | 0.000 |
Why?
|
| Calcitriol | 1 | 1980 | 173 | 0.000 |
Why?
|
| Middle Aged | 1 | 1978 | 25971 | 0.000 |
Why?
|
| Quality Control | 1 | 1977 | 117 | 0.000 |
Why?
|
| Organ Specificity | 1 | 1977 | 274 | 0.000 |
Why?
|
| Amniotic Fluid | 1 | 1975 | 30 | 0.000 |
Why?
|
| Protein Binding | 1 | 1979 | 1490 | 0.000 |
Why?
|
| Carbonic Anhydrase Inhibitors | 1 | 1974 | 5 | 0.000 |
Why?
|
| Isoniazid | 1 | 1973 | 8 | 0.000 |
Why?
|
| Physical Therapy Modalities | 1 | 1973 | 83 | 0.000 |
Why?
|
| Prednisone | 1 | 1973 | 253 | 0.000 |
Why?
|